Clinical Trial Update: Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nicotinic acid as add-on therapy to beta-blockers for preventing moderate to severe migraines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Nicotinic acid (niacin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Migraine Prophylaxis | Phase 2 | Status: COMPLETED